Level Four Advisory Services LLC lowered its position in shares of Maximus, Inc. (NYSE:MMS) by 44.5% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,692 shares of the health services provider’s stock after selling 4,562 shares during the quarter. Level Four Advisory Services LLC’s holdings in Maximus were worth $350,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Stifel Financial Corp grew its holdings in Maximus by 3.6% during the 1st quarter. Stifel Financial Corp now owns 8,731 shares of the health services provider’s stock worth $545,000 after acquiring an additional 302 shares during the last quarter. Credit Agricole S A bought a new stake in Maximus during the 1st quarter worth about $317,000. United Services Automobile Association bought a new stake in Maximus during the 1st quarter worth about $584,000. OppenheimerFunds Inc. grew its holdings in Maximus by 19.5% during the 1st quarter. OppenheimerFunds Inc. now owns 11,010 shares of the health services provider’s stock worth $685,000 after acquiring an additional 1,793 shares during the last quarter. Finally, Principal Financial Group Inc. grew its holdings in Maximus by 4.6% during the 1st quarter. Principal Financial Group Inc. now owns 267,934 shares of the health services provider’s stock worth $16,665,000 after acquiring an additional 11,829 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.
WARNING: This piece of content was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/10/27/maximus-inc-mms-holdings-trimmed-by-level-four-advisory-services-llc.html.
A number of brokerages have commented on MMS. Zacks Investment Research lowered shares of Maximus from a “buy” rating to a “hold” rating in a report on Wednesday, August 9th. Maxim Group set a $66.00 price objective on shares of Maximus and gave the stock a “hold” rating in a report on Thursday, August 3rd. BidaskClub lowered shares of Maximus from a “hold” rating to a “sell” rating in a report on Monday, July 24th. Robert W. Baird reissued a “hold” rating and set a $64.00 price objective on shares of Maximus in a report on Friday, September 1st. Finally, Canaccord Genuity lowered shares of Maximus from a “buy” rating to a “hold” rating and set a $62.00 target price on the stock. in a research note on Tuesday, July 4th. One equities research analyst has rated the stock with a sell rating and nine have given a hold rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $63.14.
Shares of Maximus, Inc. (NYSE MMS) traded up 0.11% on Friday, hitting $65.89. 61,477 shares of the stock traded hands. Maximus, Inc. has a 1-year low of $43.69 and a 1-year high of $66.65. The stock has a 50 day moving average of $64.40 and a 200-day moving average of $62.21. The stock has a market cap of $4.27 billion, a PE ratio of 21.12 and a beta of 1.36.
Maximus (NYSE:MMS) last announced its earnings results on Thursday, August 3rd. The health services provider reported $0.79 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.76 by $0.03. Maximus had a return on equity of 25.08% and a net margin of 8.43%. The business had revenue of $600.40 million for the quarter, compared to analysts’ expectations of $614.12 million. During the same period in the prior year, the business posted $0.79 earnings per share. The firm’s revenue was down 2.7% on a year-over-year basis. On average, equities research analysts expect that Maximus, Inc. will post $3.13 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Thursday, November 30th. Investors of record on Wednesday, November 15th will be issued a $0.045 dividend. This represents a $0.18 annualized dividend and a yield of 0.27%. The ex-dividend date is Tuesday, November 14th. Maximus’s payout ratio is presently 5.73%.
In other Maximus news, General Counsel David Francis sold 2,000 shares of the stock in a transaction that occurred on Friday, August 18th. The stock was sold at an average price of $58.89, for a total transaction of $117,780.00. Following the transaction, the general counsel now directly owns 13,716 shares in the company, valued at approximately $807,735.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, President Bruce Caswell sold 8,000 shares of the stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $59.83, for a total value of $478,640.00. Following the transaction, the president now owns 35,904 shares in the company, valued at $2,148,136.32. The disclosure for this sale can be found here. Insiders sold 143,403 shares of company stock worth $8,866,281 over the last quarter. 3.10% of the stock is currently owned by company insiders.
Maximus Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.